📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Coordination Pharma

1.1 - Company Overview

Coordination Pharma Logo

Coordination Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of nanoparticle-based anticancer therapies, including CPI-100, which delivers immunostimulatory chemotherapeutic combinations directly to tumors. Offers the NCP platform using nanoscale coordination polymers to develop products targeting solid tumors, and seeks partnership opportunities to enhance current cancer immunotherapies.

Products and services

  • NCP platform: A custom-engineered technology employing nanoscale coordination polymers to architect anticancer products, targeting solid tumors effectively and enabling development of NCP formulations for tumor-directed drug assemblies
  • CPI-100: A tumor-targeted nanoparticle-based drug engineered to deliver immunostimulatory chemotherapeutic combinations directly to tumors for cancer treatment, concentrating combination agents at tumor sites via nanoscale delivery
  • Partnership Opportunities: An NCP-based collaboration initiative that offers partnerships around its NCP formulations to enhance current cancer immunotherapies, enabling joint efforts to integrate nanoscale coordination polymer products with established immunotherapy regimens

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Coordination Pharma

Kronos Bio Logo

Kronos Bio

HQ: United States Website
  • Description: Provider of oncology therapies that modulate historically undruggable cancer targets. Pipeline includes KB-0742, a CDK9 inhibitor in phase 1/2 for MYC-dependent tumors, and KB-9558 targeting the p300 KAT domain for multiple myeloma. Offers a Small Molecule Microarray screening platform for transcription factor binding assays and a discovery collaboration with Genentech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kronos Bio company profile →
CoStim Logo

CoStim

HQ: United States Website
  • Description: Provider of antibody agents for cancer treatment and urban regeneration, construction, energy, and digital solutions, including the ChorusLife smart human district, general contracting (Impresa Percassi), construction envelope design and manufacturing (Gualini), global energy services (Elmet), and the GSM Platform for sustainable urban transformation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CoStim company profile →
Atrin Pharmaceuticals Logo

Atrin Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development for innovative cancer treatments. The privately held company, based in Doylestown, PA, is engaged in the discovery and development of treatments for cancer, with its most advanced program focused on a new class of highly specific compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atrin Pharmaceuticals company profile →
Living Pharma Logo

Living Pharma

HQ: United States Website
  • Description: Provider of Personalized CAR T Cell Therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Living Pharma company profile →
Northern Biologics Logo

Northern Biologics

HQ: Canada Website
  • Description: Provider of state-of-the-art antibody discovery targeting novel and challenging oncology and fibrosis targets, developing therapeutic antibody candidates derived from a phage display platform developed and refined by world-leading researchers at the University of Toronto.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Northern Biologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Coordination Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Coordination Pharma

2.2 - Growth funds investing in similar companies to Coordination Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Coordination Pharma

4.2 - Public trading comparable groups for Coordination Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Coordination Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Coordination Pharma

What does Coordination Pharma do?

Coordination Pharma is a provider of nanoparticle-based anticancer therapies, including CPI-100, which delivers immunostimulatory chemotherapeutic combinations directly to tumors. Offers the NCP platform using nanoscale coordination polymers to develop products targeting solid tumors, and seeks partnership opportunities to enhance current cancer immunotherapies.

Who are Coordination Pharma's competitors?

Coordination Pharma's competitors and similar companies include Kronos Bio, CoStim, Atrin Pharmaceuticals, Living Pharma, and Northern Biologics.

Where is Coordination Pharma headquartered?

Coordination Pharma is headquartered in United States.

How many employees does Coordination Pharma have?

Coordination Pharma has 1,000 employees 🔒.

When was Coordination Pharma founded?

Coordination Pharma was founded in 2010 🔒.

What sector and industry vertical is Coordination Pharma in?

Coordination Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Coordination Pharma

Who are the top strategic acquirers in Coordination Pharma's sector and industry

Top strategic M&A buyers and acquirers in Coordination Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Coordination Pharma?

Top strategic M&A buyers groups and sectors for Coordination Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Coordination Pharma's sector and industry vertical

Which are the top PE firms investing in Coordination Pharma's sector and industry vertical?

Top PE firms investing in Coordination Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Coordination Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Coordination Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Coordination Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Coordination Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Coordination Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Coordination Pharma?

The key public trading comparables and valuation benchmarks for Coordination Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Coordination Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Coordination Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Coordination Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Coordination Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Coordination Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Coordination Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Coordination Pharma

Launch login modal Launch register modal